Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Cellular Neuroscience|May 30, 2024
mTOR pathway inhibition alters proliferation as well as differentiation of neural stem cellsNataliya Romanyuk, Kristyna Sintakova, Ivan Arzhanov, et al.
British Journal of Pharmacology|December 23, 2011
Access of inhibitory neurosteroids to the NMDA receptorJirina Borovska, Vojtech Vyklicky, Eva Stastna, et al.
Molecular Neurobiology|February 5, 2016
Pax2-Islet1 Transgenic Mice Are Hyperactive and Have Altered Cerebellar FoliationRomana Bohuslavova, Nicole Dodd, Iva Macova, et al.
Molecular Genetics and Metabolism|October 8, 2021
Variants in the MIPEP gene presenting with complex neurological phenotype without cardiomyopathy, impair OXPHOS protein maturation and lead to a reduced OXPHOS abundance in patient cellsJuliette Pulman, Benedetta Ruzzenente, Martin Horak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 15, 2020
N-linked glycosylation of the mGlu7 receptor regulates the forward trafficking and transsynaptic interaction with Elfn1Da-Ha Park, Sunha Park, Jae-Man Song, et al.
Frontiers in Molecular Neuroscience|June 20, 2018
N-Glycosylation Regulates the Trafficking and Surface Mobility of GluN3A-Containing NMDA ReceptorsKristyna Skrenkova, Sanghyeon Lee, Katarina Lichnerova, et al.
Scientific Reports|July 30, 2020
Cholesterol modulates presynaptic and postsynaptic properties of excitatory synaptic transmissionMiloslav Korinek, Inmaculada M Gonzalez-Gonzalez, Tereza Smejkalova, et al.
Steroids|September 20, 2011
Neurosteroid modulation of N-methyl-D-aspartate receptors: molecular mechanism and behavioral effectsMiloslav Korinek, Vojtech Kapras, Vojtech Vyklicky, et al.
The Journal of Biological Chemistry|June 6, 2015
Two N-glycosylation Sites in the GluN1 Subunit Are Essential for Releasing N-methyl-d-aspartate (NMDA) Receptors from the Endoplasmic ReticulumKatarina Lichnerova, Martina Kaniakova, Seung Pyo Park, et al.
British Journal of Pharmacology|March 23, 2022
Pregnane-based steroids are novel positive NMDA receptor modulators that may compensate for the effect of loss-of-function disease-associated GRIN mutationsBohdan Kysilov, Barbora Hrcka Krausova, Vojtech Vyklicky, et al.
Pageof 6